Search Results - "Chazov, E. I."

Science and clinical practice by Chazov, E I

“…The paper discusses issues related to the role of basic studies in the development of practical medicine and to the integration of basic science and medical…”
Get full text

Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter by Maykov, E B, Yuricheva, Yu A, Mironov, N Yu, Sokolov, S F, Golitsyn, S P, Rozenshtraukh, L V, Chazov, E I

“…To evaluate the efficacy and safety of refralon (niferidil), a new class III antiarrhythmic agent whose activity is related to the block of delayed rectifying…”
Get full text

Hemodynamic effects of the synthetic analogue of endogenous nitric oxide (II) donors a dinitrosyl iron complex in hypertensive patients with uncomplicated hypertensive crisis by Gosteev, A Iu, Zorin, A V, Rodnenkov, O V, Dragnev, A G, Chazov, E I

“…To examine the antihypertensive effect of the synthetic analogue of the endogenous nitric oxide donors in patients with grades 2-3 hypertension and…”
Get full text

Effects of anomalous rise of air temperature on population mortality by Chazov, E I, Boĭtsov, S A

“…Global climate warming for the last 10 years actualized the problem of mortality rise in some European countries in anomalous summer heat. Russia faced this…”
Get full text

Fundamental medicine as a basis of innovations in medical practice by Chazov, E I

Get full text

Progress in fundamental research: perspectives of cardiology by Chazov, E I

“…Recent research performed in the Cardiology Research Center (CRC) and on-going studies reviewed in the article confirm the hypothesis suggested by CRC…”
Get full text

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness by Mironov, N. Yu, Vlodzyanovskiy, V. V., Yuricheva, Yu. A., Sokolov, S. F., Golitsyn, S. P., Rosenstraukh, L. V., Chazov, E. I.

“…Aim. We aimed to compare effectiveness of new  class III antiarrhythmic drug  Refralon with direct current  cardioversion (DCC) in patients with persistent…”
Get full text

Fibrinolytics: from the thrombolysis to the processes of blood vessels growth and remodeling, neurogenesis, carcinogenesis and fibrosis by Tkachuk, V A, Parfyonova, Ye V, Plekhanova, O S, Stepanova, V V, Menshikov, M Yu, Semina, E V, Bibilashvili, R Sh, Chazov, E I

“…One of the most outstanding scientific achievements in the thrombolysis is the development and administration of fibrinolysin - the first Soviet drug that…”
Get full text

Acute renal failure caused by cholesterol embolism of the intrarenal arteries after coronaroangiography: success of glucocorticosteroid treatment by Chazov, E I, Mukhin, N A, Zharova, E A, Fomin, V V

Get full text

How to reduce mortality from cardiovascular diseases by Chazov, E I

Get full text

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety by Mironov, N. Yu, Vlodzyanovskiy, V. V., Yuricheva, Yu. A., Sokolov, S. F., Golitsyn, S. P., Rosenstraukh, L. V., Chazov, E. I.

“…Aim. To compare safety of new class III antiarrhythmic drug Refralon with direct current cardioversion (DCC) in patients with persistent atrial fibrillation…”
Get full text

Synthetic peptide fragment (65–76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting by Arefieva, T. I., Krasnikova, T. L., Potekhina, A. V., Ruleva, N. U., Nikitin, P. I., Ksenevich, T. I., Gorshkov, B. G., Sidorova, M. V., Bespalova, Zh. D., Kukhtina, N. B., Provatorov, S. I., Noeva, E. A., Chazov, E. I.

“…Objective and design The peptide from C-terminal domain of MCP-1 (Ingramon) has been shown to inhibit monocyte migration and possess anti-inflammatory activity…”
Get full text

Prospects of designing the medicines with diverse therapeutic activity on the basis of dinitrosyl iron complexes with thiol-containing ligands by Vanin, A F, Chazov, E I

“…A stable hypotensive preparation (Oxacom) based on dinitrosyl iron complexes (DNIC) with glutathione has been developed. The preparation has successfully…”
Get more information

Clinico-epidemiological program of the study of depression in cardiological practice in patients with hypertension and ischemic heart disease: first results of a multicenter study by Chazov, E I, Oganov, R G, Pogosova, G V, Shal'nova, S A, Romasenko, L V, Shchurov, D V

Get more information

Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study by Chazov, E I, Lepakchin, V K, Zharova, E A, Fitilev, S B, Levin, A M, Rumiantzeva, E G, Fitileva, T B

“…The aim of this study was to assess the efficacy and acceptability of trimetazidine (TMZ) in combination with hemodynamic agents (beta-blockers or long-acting…”
Get full text

Protective systems of the human organism as a basis of search and development of new original medical drugs by Chazov, E I

Get more information

Ion transport, membrane fluidity and haemoglobin conformation in erythrocyte from patients with cardiovascular diseases: Role of augmented plasma cholesterol by Luneva, O.G., Brazhe, N.A., Maksimova, N.V., Rodnenkov, O.V., Parshina, E.Yu, Bryzgalova, N.Yu, Maksimov, G.V., Rubin, A.B., Orlov, S.N., Chazov, E.I.

“…Tissue hypoxia, which plays a key role in the development of renal and vascular complications of cardiovascular diseases (CVD), might be considered a…”
Get full text

The role of fundamental science achievements in raising treatment efficacy by Chazov, E I

Get more information

Novel class III antiarrhythmic agent niferidile: review of experimental and clinical studies by Maĭkov, E B, Iuricheva, Iu A, Mironov, N Iu, Sokolov, S F, Golitsyn, S P, Rozenshtraukh, L V, Chazov, E I

“…This article reviews experimental and clinical studies of a novel antiarrhythmic agent niferidile. Niferidile, a class III antiarrhythmic agent, blocks…”
Get more information

The effect of histamine receptor antagonists on stress-induced catecholamine secretion: an adrenomedullary microdialysis study in the rat by Kuzmin, Alexander I, Zaretsky, Dmitry V, Kalenikova, Elena I, Zaretskaja, Maria V, Medvedev, Oleg S, Chazov, Evgenyi I

“…The effects of pretreatment with selective histamine receptor antagonists on changes in sympathoadrenal activity and haemodynamics, induced by 60-min…”
Get full text